Literature DB >> 18514697

Management of extremity soft tissue sarcomas.

Matthew T Hueman1, Katherine Thornton, Joseph M Herman, Nita Ahuja.   

Abstract

This article provides an understanding of the evaluation, staging, and management of patients with extremity soft tissue sarcoma. Although there are straightforward guidelines to the management of patients with extremity soft tissue sarcoma, each patient presents with a unique tumor, and considerations for tumor control, functional outcome, and the toxicity of therapy must be considered. As is true for patients diagnosed with sarcoma at other anatomic sites, a multidisciplinary team approach streamlines care with attention to the complexities and intricacies of choosing and delivering optimal therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18514697     DOI: 10.1016/j.suc.2008.04.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

1.  Surgery for retroperitoneal soft tissue sarcomas: aggressive re-resection of recurrent disease is possible.

Authors:  R Lochan; J J French; D M Manas
Journal:  Ann R Coll Surg Engl       Date:  2010-09-07       Impact factor: 1.891

2.  Outcomes of Planned Marginal and Wide Resection of Sarcomas Associated with Major Vascular Structures in Extremities.

Authors:  Ahmet Fevzi Kekeç; İlknur Günaydın; Recep Öztürk; Bedii Şafak Güngör
Journal:  Indian J Surg Oncol       Date:  2021-11-22

3.  Synovial sarcoma of anterior abdominal wall.

Authors:  Sangeetha Jayaraman; S Devaji Rao; Meera Govindarajan
Journal:  Indian J Surg       Date:  2010-10-20       Impact factor: 0.656

4.  Management of soft tissue tumors of the upper extremity: a review.

Authors:  Kevin T Jubbal; Gehaan D'Souza; Reid A Abrams; Anna A Kulidjian
Journal:  SICOT J       Date:  2017-06-28

5.  Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS).

Authors:  Barbara Röper; Christine Heinrich; Victoria Kehl; Hans Rechl; Katja Specht; Klaus Wörtler; Andreas Töpfer; Michael Molls; Severin Kampfer; Rüdiger von Eisenharth-Rothe; Stephanie E Combs
Journal:  BMC Cancer       Date:  2015-11-16       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.